BackInventiva S.A. Overview
Inventiva S.A.

Inventiva S.A. P/E Ratio

Latest P/E ratio for Inventiva S.A.: -6.0 — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

P/E Ratio

-6.00

P/E Ratio

-6.00

The P/E ratio compares a company's stock price to its earnings per share. A lower P/E ratio may indicate that the stock is undervalued.

P/E Ratio (Comparison Companies)

Loading

P/E Ratio History

Loading

P/E Ratio Comparison

Loading

Inventiva S.A. (IVEVF) FAQ

Inventiva S.A. (IVEVF) currently reports a P/E ratio of -6.0. That is below the Healthcare sector average of 70.94. Use the charts on this page to explore Inventiva S.A.'s P/E ratio history and peer comparisons.

Inventiva S.A.'s P/E ratio of -6.0 is lower than the Healthcare sector average of 70.94. That is roughly 108.5% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

The P/E ratio is a valuation multiple that relates Inventiva S.A.'s market price to a fundamental measure such as earnings, sales, or book value. At -6.0, IVEVF can look expensive or cheap only in context — versus its own history, growth rate, and Healthcare peers. Higher multiples often price in stronger expected growth; lower ones can signal value or concern.

Start with the current P/E ratio of -6.0, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 70.94. From there, open related valuation or income-statement pages for Inventiva S.A., and consider following IVEVF for alerts when major investors trade the stock.

Inventiva S.A. is classified in the Healthcare sector. On P/E ratio, it currently shows -6.0 versus a sector average near 70.94. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing IVEVF with unrelated industries.